These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Covalent α-synuclein dimers: chemico-physical and aggregation properties. Pivato M; De Franceschi G; Tosatto L; Frare E; Kumar D; Aioanei D; Brucale M; Tessari I; Bisaglia M; Samori B; de Laureto PP; Bubacco L PLoS One; 2012; 7(12):e50027. PubMed ID: 23272053 [TBL] [Abstract][Full Text] [Related]
7. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease. Galvagnion C J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142 [TBL] [Abstract][Full Text] [Related]
9. The influence of N-terminal acetylation on micelle-induced conformational changes and aggregation of α-Synuclein. Ruzafa D; Hernandez-Gomez YS; Bisello G; Broersen K; Morel B; Conejero-Lara F PLoS One; 2017; 12(5):e0178576. PubMed ID: 28562630 [TBL] [Abstract][Full Text] [Related]
10. Transient Lipid-Protein Structures and Selective Ganglioside Uptake During α-Synuclein-Lipid Co-aggregation. Gaspar R; Idini I; Carlström G; Linse S; Sparr E Front Cell Dev Biol; 2021; 9():622764. PubMed ID: 33681202 [TBL] [Abstract][Full Text] [Related]
11. Computational insights into the role of α-strand/sheet in aggregation of α-synuclein. Balupuri A; Choi KE; Kang NS Sci Rep; 2019 Jan; 9(1):59. PubMed ID: 30635607 [TBL] [Abstract][Full Text] [Related]
12. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation. Galvagnion C; Marlet FR; Cerri S; Schapira AHV; Blandini F; Di Monte DA Brain; 2022 Apr; 145(3):1038-1051. PubMed ID: 35362022 [TBL] [Abstract][Full Text] [Related]
13. Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation. Flagmeier P; Meisl G; Vendruscolo M; Knowles TP; Dobson CM; Buell AK; Galvagnion C Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10328-33. PubMed ID: 27573854 [TBL] [Abstract][Full Text] [Related]
14. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. Uversky VN; Li J; Fink AL J Biol Chem; 2001 Nov; 276(47):44284-96. PubMed ID: 11553618 [TBL] [Abstract][Full Text] [Related]
15. Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics. Hellstrand E; Grey M; Ainalem ML; Ankner J; Forsyth VT; Fragneto G; Haertlein M; Dauvergne MT; Nilsson H; Brundin P; Linse S; Nylander T; Sparr E ACS Chem Neurosci; 2013 Oct; 4(10):1339-51. PubMed ID: 23823878 [TBL] [Abstract][Full Text] [Related]
17. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease. Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963 [TBL] [Abstract][Full Text] [Related]
18. Elucidating the Role of Lipids in the Aggregation of Amyloidogenic Proteins. Kurouski D Acc Chem Res; 2023 Nov; 56(21):2898-2906. PubMed ID: 37824095 [TBL] [Abstract][Full Text] [Related]
19. GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro. Fazzari M; Di Biase E; Zaccagnini L; Henriques A; Callizot N; Ciampa MG; Mauri L; Carsana EV; Loberto N; Aureli M; Mari L; Civera M; Vasile F; Sonnino S; Bartels T; Chiricozzi E; Lunghi G Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159350. PubMed ID: 37330108 [TBL] [Abstract][Full Text] [Related]
20. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution. Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]